References
- http://www.cancer.gov.co, accesed January 2012. Instituto Nacional de Cancerología. Anuario Estadístico 2007.
- Díaz S, Piñeros M, Sánchez O. Detección temprana del cáncer de mama: aspectos críticos para un programa de tamizaje organizado en Colombia. Revista Colombiana de Cancerología 2005; 9:93 - 105
- Fleming TP, Watson MA. Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer. Ann N Y Acad Sci 2000; 923:78 - 89; http://dx.doi.org/10.1111/j.1749-6632.2000.tb05521.x; PMID: 11193781
- Watson MA, Fleming TP. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res 1996; 56:860 - 5; PMID: 8631025
- Carter D, Douglass JF, Cornellison CD, Retter MW, Johnson JC, Bennington AA, et al. Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer. Biochemistry 2002; 41:6714 - 22; http://dx.doi.org/10.1021/bi0159884; PMID: 12022875
- Zehentner BK, Carter D. Mammaglobin: a candidate diagnostic marker for breast cancer. Clin Biochem 2004; 37:249 - 57; http://dx.doi.org/10.1016/j.clinbiochem.2003.11.005; PMID: 15003725
- Fanger GR, Houghton RL, Retter MW, Hendrickson RC, Babcook J, Dillon DC, et al. Detection of mammaglobin in the sera of patients with breast cancer. Tumour Biol 2002; 23:212 - 21; http://dx.doi.org/10.1159/000067251; PMID: 12499777
- Zehentner BK, Persing DH, Deme A, Toure P, Hawes SE, Brooks L, et al. Mammaglobin as a novel breast cancer biomarker: multigene reverse transcription-PCR assay and sandwich ELISA. Clin Chem 2004; 50:2069 - 76; http://dx.doi.org/10.1373/clinchem.2004.038687; PMID: 15375015
- Bernstein JL, Godbold JH, Raptis G, Watson MA, Levinson B, Aaronson SA, et al. Identification of mammaglobin as a novel serum marker for breast cancer. Clin Cancer Res 2005; 11:6528 - 35; http://dx.doi.org/10.1158/1078-0432.CCR-05-0415; PMID: 16166429
- Watson MA, Dintzis S, Darrow CM, Voss LE, DiPersio J, Jensen R, et al. Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res 1999; 59:3028 - 31; PMID: 10397237
- Okami J, Dohno K, Sakon M, Iwao K, Yamada T, Yamamoto H, et al. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma. Clin Cancer Res 2000; 6:2326 - 32; PMID: 10873083
- Huang Y, Zhang HQ, Wang J, Song XG, Wang GH, Guan Q, et al. Cloning expression, monoclonal antibody preparation and serologic study of mammaglobin in breast cancer. Neoplasma 2011; 58:436 - 40; http://dx.doi.org/10.4149/neo_2011_05_436; PMID: 21744998
- Núñez-Villar MJ, Martínez-Arribas F, Pollán M, Lucas AR, Sánchez J, Tejerina A, et al. Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype. Breast Cancer Res 2003; 5:R65 - 70; http://dx.doi.org/10.1186/bcr587; PMID: 12793902
- Vogel FR, Hem SL. Immunologic Adjuvants. In: Plotkin SA, Orenstein WA eds. Vaccines. 4th edn. Filadelfia: Elsevier Inc. 2004;69-79.